The antitumor monoclonal antibody 806 recognizes a high‐mannose form of the EGF receptor that reaches the cell surface when cells over‐express the receptor-Reference-Cited by-同舟云学术

The antitumor monoclonal antibody 806 recognizes a high‐mannose form of the EGF receptor that reaches the cell surface when cells over‐express the receptor

Published:2005-03-17 Issue:7 Volume:19 Page:1-18
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Johns Terrance G.¹,Mellman Ira²,Cartwright Glenn A.¹,Ritter Gerd³,Old Lloyd J.³,Burgess Antony W.⁴,Scott Andrew M.¹

Affiliation:

1. Ludwig Institute for Cancer ResearchTumour Targeting ProgramAustin Hospital Heidelberg Australia

2. Epithelial Biochemistry LaboratoryRoyal Melbourne Hospital Parkville Australia

3. Department of Cell BiologyLudwig Institute for Cancer ResearchYale University School of Medicine New Haven Connecticut

4. Ludwig Institute for Cancer ResearchNew York BranchMemorial Sloan-Kettering Cancer Center New York

Funder

National Health and Medical Research Council

Garnett Passe and Rodney Williams Memorial Foundation

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.04-1766fje

Reference39 articles.

1. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia

2. Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy

3. Chemoprevention of Breast Cancer: A Model for Change

4. EGFR and cancer prognosis

5. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors;Moscatello D. K.;Cancer Res.,1995

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of²²⁵Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models;Journal of Nuclear Medicine;2024-07-25

2. Spatial N-glycomics of the normal breast microenvironment reveals fucosylated and high-mannose N-glycan signatures related to BI-RADS density and ancestry;Glycobiology;2024-06-13

3. Design of antigens to present a tumor-specific cryptic epitope;2024-04-17

4. Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities;International Journal of Molecular Sciences;2024-02-15

5. Sensitive and Specific Global Cell Surface N-Glycoproteomics Shows Profound Differences Between Glycosylation Sites and Subcellular Components;Analytical Chemistry;2023-11-13